Skip to main content
Pharmaron Beijing Co., Ltd. logo

Pharmaron Beijing Co., Ltd. — Investor Relations & Filings

Ticker · 300759 ISIN · CNE100003JW4 LEI · 300300JYXHGVS5SNGG54 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,323 across all filing types
Latest filing 2025-08-21 Remuneration Information
Country CN China
Listing Shenzhen Stock Exchange 300759

About Pharmaron Beijing Co., Ltd.

https://www.pharmaron.cn

Pharmaron Beijing Co., Ltd. is a premier R&D service provider for the life sciences industry, offering a comprehensive, fully integrated platform for drug discovery, development, and manufacturing. The company supports global pharmaceutical and biotechnology partners through a wide range of services, including laboratory chemistry, biology, DMPK, pharmacology, and safety assessment. Its capabilities extend to clinical development services and commercial-scale manufacturing for small molecules, biologics, and cell and gene therapies. By leveraging advanced technology and a global network of facilities, the company facilitates the transition of drug candidates from initial concept to market approval, optimizing the efficiency and success of the drug development lifecycle.

Recent filings

Filing Released Lang Actions
关于调整2021年、2022年、2023年A股限制性股票激励计划相关事项的公告
Remuneration Information Classification · 95% confidence The document is an announcement regarding adjustments to the restricted stock incentive plans for the years 2021, 2022, and 2023. It details changes in the grant prices of restricted shares under these plans, references board and supervisory meetings, and includes legal opinions and approvals. The content focuses on stock incentive plan adjustments and related corporate governance matters rather than financial results, earnings, or full reports. It is not a full annual or interim report, nor an earnings release or investor presentation. It is also not a proxy solicitation or voting results announcement. The document is a formal announcement of changes related to management compensation plans (stock incentives), which fits best under Remuneration Information filings, as it relates to executive and employee compensation plans and their adjustments.
2025-08-21 Chinese
关于追加投资境外参股公司暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the company's additional investment in an overseas associate company and related party transactions. It includes comprehensive information about the investment background, transaction details, counterparties, financial data of the associate, pricing policy, related party arrangements, transaction purpose and impact, authorization, cumulative related party transactions, board opinions, independent directors' review, and reference documents. The document is lengthy (8678 characters) and contains substantive financial and transactional data. It is not a full annual or interim report, nor an earnings release or call transcript. It is not a simple announcement of a report publication or a certification. The content focuses on a capital increase and related party transaction, which fits the category of Capital/Financing Update (CAP). Therefore, the appropriate classification is CAP with high confidence.
2025-08-21 Chinese
关于完成工商变更登记并换发营业执照的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of business registration changes and the issuance of a new business license. It references prior shareholder meetings where capital increase and amendments to the company charter were approved, but this document itself is an official notice of the completion of those registration changes with the market supervision authority. The document length is short (864 characters) and it does not contain financial statements or detailed financial data. It is not a report or financial filing but a regulatory announcement about corporate registration updates. Therefore, it fits best under Regulatory Filings (RNS).
2025-08-08 Chinese
H股公告
Board/Management Information Classification · 95% confidence The document is a notice announcing a board meeting scheduled for August 21, 2025, to review and approve the company's interim results for the six months ending June 30, 2025. It is a brief announcement about the meeting date and agenda, not the actual interim report or financial data. The document length is short (539 characters), and it does not contain financial statements or substantive analysis. Therefore, it is a Board/Management Information announcement regarding the board meeting, not the interim report itself.
2025-08-07 Chinese
H股公告
Share Issue/Capital Change Classification · 95% confidence The document is a monthly securities movement report for a listed company, 康龍化成（北京）新藥技術股份有限公司, submitted to the Hong Kong Stock Exchange. It details changes in registered capital, issued shares, treasury shares, and stock option plans, with no financial statements or earnings data. The document is 4026 characters long, which is relatively short and focused on share capital and shareholding changes rather than financial performance or management commentary. It is not an announcement of a report publication but a regulatory filing of share capital and shareholding changes as required by the exchange rules. This fits the category of Share Issue/Capital Change (SHA) as it reports on share capital and shareholding movements, including treasury shares and stock incentive plans. Therefore, the correct classification is SHA with high confidence.
2025-08-06 Chinese
关于公司实际控制人股份质押和解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the pledge and release of shares by the company's actual controller and other shareholders. It details the number of shares pledged, released, and the related dates, as well as the impact on the company's control and operations. There is no financial statement, earnings data, or management discussion. The document is a regulatory disclosure about share pledging activities, which fits the category of Major Shareholding Notification (MRQ) as it involves significant share ownership changes and pledges by major shareholders. The document length is 2517 characters, which is typical for such announcements and not a full financial report or earnings release.
2025-08-01 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.